Skip to content

Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression

Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression - A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02850341
Acronym
SAD
Enrollment
292
Registered
2016-08-01
Start date
2016-07-31
Completion date
2020-01-31
Last updated
2021-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Physical Activity, Mental Health, Health Behavior, Walking, Physical Exercise, Mental disorder

Brief summary

The purpose of this study is to determine if the use of pedometers can help depressive inpatients in psychiatric clinics to increase their level of physical activity. Therefore patients are given a pedometer and instructions how to raise their level of daily steps. Intervention group is compared with a control group that is receiving treatment-as-usual. The intervention is hypothesized to increase number of daily steps and have positive effects on mood, depression and anxiety.

Interventions

DEVICEPedometer

Patients receive a pedometer with instructions how to raise their number of daily steps

Sponsors

Robert-Enke-Stiftung
CollaboratorUNKNOWN
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Major Depression, moderate to severe as main diagnosis * Inpatient status * Prospected inpatient treatment of at least 4 weeks * Able to understand german

Exclusion criteria

* Physical disease or disability that makes it impossible to reach the goal 5000 steps per day * Borderline personality disorder * Bipolar Disorder * Schizophrenia * Anorexia Nervosa * Dementia * Psychotic Depression * Pregnancy * Acute suicidality * Substance dependancies with actual consumption (except nicotine) * Current pedometer-use * More than 10.000 steps per day

Design outcomes

Primary

MeasureTime frameDescription
Change in average number of steps per dayFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Number of steps per day is objectively measured using accelerometry (ActiGraph GT1M)
Change in depressive symptoms - clinician ratedFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Depressive symptoms are rated by a blind study employee using MADRS

Secondary

MeasureTime frameDescription
Change in psychopathological symptomsFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Psychopathological symptoms are measured by the Symptom Checklist 27 (SCL-27)
Change in health-related quality of lifeFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Health-related quality of life is measured using the Short-Form Health Questionnaire (SF-12)
Change in depressive symptomsFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Depressive symptoms are measured using the Beck Depression Inventory (BDI II)
Change in anxiety symptomsFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Anxiety symptoms are measured using the Beck Anxiety Inventory (BAI)
Change in self-efficacy for physical activityFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Self-efficacy for physical activity is measured using six likert scaled items by Scholz, U., Sniehotta, F. & Schwarzer, R. (2005)
Change in physical activity - subjectiveFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Physical activity is subjectively measured with the International Physical Activity Questionnaire (IPAQ)
Change in self concordance of the motivation for physical activityFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Self concordance of the Motivation for physical activity is measured using the Sport- und bewegungsbezogene Selbstkonkordanz Skala, which consists of 12 likert scaled items
Change in outcome expectancies for physical activityFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Outcome expectancies for physical activity are measured using 6 likert scaled items by Lippke S., Ziegelmann, J. P. & Schwarzer, R. (2005)
Change in planning and barrier planning for physical activityFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Planning and barrier planning for physical activity is measured using 8 likert scaled items by Sniehotta, F. F. et al. (2005) / Renner, B. (2007)
Duration of inpatient treatment (Number of days)Duration of inpatient treatment is assessed at the end of inpatient treatment
Change in general self-efficacyFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)General self-efficacy is measured using the General-Self-Efficacy Scale (GSE)
Change in intention for physical activityFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Intention for physical activity is measured using two likert scaled items by Sniehotta, F. F., Schwarzer, R., Scholz, U., & Schüz, B. (2005)
Change in physical activity - objectiveFrom baseline (1.-3. day of inpatient treatment) to end of inpatient treatment (3 days before end of inpatient treatment)Physical activity is objectively measured using accelerometry (ActiGraph GT1M)

Countries

Austria, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026